Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Candidate predictive biomarkers for epidermal growth factor receptor inhibitors (EGFRi), skin rash and serum proteomic assays, require further qualification to improve EGFRi therapy in non-small cell lung cancer (NSCLC). |